Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer	Cancer of the Uterine Cervix, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder	Active, not recruiting	Phase 2	2025-03-20		NCT04516616

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Army Medical University, China	10
Chongqing University Cancer Hospital	41
First Affiliated Hospital of Chongqing Medical University	101
Huazhong University of Science and Technology	83
Obstetrics & Gynecology Hospital of Fudan University	36
Peking University People's Hospital	269
Qilu Hospital of Shandong University	249
The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)	8
The Second Affiliated Hospital of Harbin Medical University	36
Tianjin Medical University General Hospital	80
Women's Hospital School Of Medicine Zhejiang University	60

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Tongji Hospital	Wuhan	China	13